In at-risk patients without CVD, polypill plus aspirin reduced a composite of major CV events at 4.6 y
- PMID: 33819061
- DOI: 10.7326/ACPJ202104200-041
In at-risk patients without CVD, polypill plus aspirin reduced a composite of major CV events at 4.6 y
Abstract
Yusuf S, Joseph P, Dans A, et al. Polypill with or without aspirin in persons without cardiovascular disease. N Engl J Med. 2021;384:216-28. 33186492.
Keywords: Adrenergic beta-antagonists; Angiotensin-converting enzyme inhibitors; Antihypertensive agents; Cardiovascular diseases; Hydroxymethylglutaryl-CoA reductase inhibitors; Platelet aggregation inhibitors.
Comment on
-
Polypill with or without Aspirin in Persons without Cardiovascular Disease.N Engl J Med. 2021 Jan 21;384(3):216-228. doi: 10.1056/NEJMoa2028220. Epub 2020 Nov 13. N Engl J Med. 2021. PMID: 33186492 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical